Stcube에스티큐브
052020 · KOSDAQ · ₩052020 · 에스티큐브
₩6,940▲ ₩220 (3.27%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Oct 30, 2026Open on DART
Predicted impact: Low
- Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 14, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
- Audit report submitted감사보고서제출Mar 18, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 25, 2026Open on DART
- Amended: Notice of shareholders' meeting[기재정정]주주총회소집공고Feb 25, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 24, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Feb 20, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 20, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 12, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (Nelmastobart(hSTC810)의 진행성/전이성 비소세포폐암 제2상 임상시험계획 승인)Oct 16, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Sep 18, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (Nelmastobart(hSTC810)의 진행성/전이성 비소세포폐암 제2상 임상시험계획 신청)Aug 25, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획자진취하등) (면역항암제 hSTC810 의 미국 식품의약국(FDA) 제1b/2상 임상 시험계획(IND) 자진취하)Aug 25, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
- Amended: Annual report (Dec 2024)[기재정정]사업보고서 (2024.12)Aug 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 30, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (면역항암제 Nelmastobart(hSTC810)의 전이성/재발성 대장암 제1b/2상 임상시험계획(IND) 승인 )Mar 20, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 19, 2025Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 19, 2025Open on DART
- Audit report submitted감사보고서제출Mar 11, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 11, 2025Open on DART
- [Amended] Reference Document for Proxy Solicitation of Voting Rights[기재정정]의결권대리행사권유참고서류Mar 4, 2025Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 28, 2025Open on DART
- Notice of shareholders' meeting주주총회소집공고Feb 28, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Feb 26, 2025Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 18, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청) (면역항암제 Nelmastobart(hSTC810)의 전이성/재발성 대장암 제1b/2상 임상시험계획 신청 (IND))Feb 18, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2024Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 3, 2024Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 3, 2024Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 3, 2024Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 3, 2024Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Dec 3, 2024Open on DART
- Results of Securities Issuance (Voluntary Disclosure) (Rights Offering)증권발행결과(자율공시) (주주우선공모증자)Nov 29, 2024Open on DART
- Securities Issuance Results Report증권발행실적보고서Nov 29, 2024Open on DART
- Subscription Results of Rights Offering or Stock-Related Bonds, etc. (Voluntary Disclosure)유상증자또는주식관련사채등의청약결과(자율공시)Nov 28, 2024Open on DART
- Subscription Results for Rights Offering or Stock-Related Bonds (Voluntary Disclosure) (Shareholder Priority Public Offering)유상증자또는주식관련사채등의청약결과(자율공시) (주주우선공모증자)Nov 25, 2024Open on DART
- Final Determination of Issue Price for Rights Offering유상증자최종발행가액확정Nov 19, 2024Open on DART
- Amended: Prospectus[기재정정]투자설명서Nov 19, 2024Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Nov 19, 2024Open on DART
- Amended: Prospectus[기재정정]투자설명서Nov 19, 2024Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Nov 19, 2024Open on DART
- Amended: Securities registration statement[기재정정]증권신고서(지분증권)Nov 4, 2024Open on DART
- Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 1, 2024Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 30, 2024Open on DART
Titles in Korean until English translations are added.
Also known as: Stcube / 에스티큐브 / 052020 / KRX:052020
Source: KRX statistical information